Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0c8fb7e85a6f61273fe3472d4fc675e5 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-146 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 |
filingDate |
2005-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2008-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db7970d22cbf985aebe83fa8827fd66e |
publicationDate |
2008-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1796642-B1 |
titleOfInvention |
Pharmaceutical compositions in the form of solid dispersions for the treatment of cancer |
abstract |
This invention relates to novel pharmaceutical compositions comprising a solid dispersion of the compound of Formula I below, to processes for preparing these novel pharmaceutical compositions and to their use for treating hyper-proliferative disorders, such as cancer, either as a sole agent or in combination with other therapies. Formula I is as follows: |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10213433-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10730873-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9872861-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10081628-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9840502-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11369599-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9345702-B2 |
priorityDate |
2004-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |